Literature DB >> 19840136

The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study.

Siran M Koroukian1, Bassam Dahman, Glenn Copeland, Cathy J Bradley.   

Abstract

OBJECTIVE: To compare the adequacy of the state buy-in variable (SBI) in the Medicare denominator file to identify dually eligible patients. DATA SOURCE/STUDY SETTINGS: We used linked Medicare and Medicaid data from Michigan and Ohio for elders diagnosed with incident breast, prostate, or colorectal cancer between 1996 and 2001. STUDY
DESIGN: Using the Medicaid enrollment file as the "gold standard," we assessed the number of duals from Medicare files in cross-sectional and longitudinal analyses. DATA COLLECTION/EXTRACTION
METHODS: Data for the study population were linked with Medicare and Medicaid files using patient identifiers. PRINCIPAL
FINDINGS: Sensitivity was low (74.2 percent, 95 percent confidence interval [CI]: 72.7, 75.6 and 80.8 percent, 79.7, 81.9, in Michigan and Ohio, respectively). PPV was above 95 percent in Michigan and 88.8 percent in Ohio. Both sensitivity and PPV varied between and within the states. Both in Michigan and in Ohio, we observed limited agreement on the length of enrollment in Medicaid between the two data sources.
CONCLUSIONS: Except to examine disparities by dual status at a very broad level, the SBI variable alone may be inadequate to identify duals. The findings call for improvements in Medicare and Medicaid information management systems and for uniformity in database linking strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19840136      PMCID: PMC2813448          DOI: 10.1111/j.1475-6773.2009.01051.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  14 in total

1.  Assessing the effectiveness of Medicaid in breast and cervical cancer prevention.

Authors:  Siran M Koroukian
Journal:  J Public Health Manag Pract       Date:  2003 Jul-Aug

2.  Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status.

Authors:  Siran M Koroukian; Fang Xu; Avi Dor; Gregory S Cooper
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

3.  Linking the Ohio Cancer Incidence Surveillance System with Medicare, Medicaid, and Clinical Data from Home Health Care and Long Term Care Assessment Instruments: Paving the Way for New Research Endeavors in Geriatric Oncology.

Authors:  Siran M Koroukian
Journal:  J Registry Manag       Date:  2008

4.  Medicaid status and stage at diagnosis of cervical cancer.

Authors:  Cynthia D O'Malley; Sarah J Shema; Lisa S Clarke; Christina A Clarke; Carin I Perkins
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

5.  Absence of cancer diagnosis and treatment in elderly Medicaid-insured nursing home residents.

Authors:  Cathy J Bradley; Jan P Clement; Chunchieh Lin
Journal:  J Natl Cancer Inst       Date:  2007-12-25       Impact factor: 13.506

6.  Late stage cancers in a Medicaid-insured population.

Authors:  Cathy J Bradley; Charles W Given; Caralee Roberts
Journal:  Med Care       Date:  2003-06       Impact factor: 2.983

7.  Cancer incidence in elderly Medicare and dually eligible beneficiaries.

Authors:  Cathy J Bradley; Zhehui Luo; Charles W Given
Journal:  Health Serv Res       Date:  2008-05-12       Impact factor: 3.402

8.  Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer.

Authors:  Cathy J Bradley; Charles W Given; Bassam Dahman; Timothy L Fitzgerald
Journal:  Arch Intern Med       Date:  2008-03-10

9.  Disabled Medicare beneficiaries by dual eligible status: California, 1996-2001.

Authors:  June E O'Leary; Elizabeth M Sloss; Glenn Melnick
Journal:  Health Care Financ Rev       Date:  2007

10.  Dually eligible enrollees: 2002.

Authors:  Terry R Lied
Journal:  Health Care Financ Rev       Date:  2006
View more
  21 in total

1.  Colonoscopist and primary care physician supply and disparities in colorectal cancer screening.

Authors:  Jaime Benarroch-Gampel; Kristin M Sheffield; Yu-Li Lin; Yong-Fang Kuo; James S Goodwin; Taylor S Riall
Journal:  Health Serv Res       Date:  2011-12-08       Impact factor: 3.402

2.  Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  Lung Cancer       Date:  2016-05-31       Impact factor: 5.705

3.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

4.  Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.

Authors:  Gabriela Schmajuk; Amal N Trivedi; Daniel H Solomon; Edward Yelin; Laura Trupin; Eliza F Chakravarty; Jinoos Yazdany
Journal:  JAMA       Date:  2011-02-02       Impact factor: 56.272

5.  Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.

Authors:  Kenneth L Kehl; Christopher S Lathan; Bruce E Johnson; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506

6.  How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis.

Authors:  Saad A Khan; Sandi L Pruitt; Lei Xuan; Una Makris; David E Gerber
Journal:  Lung Cancer       Date:  2017-11-24       Impact factor: 5.705

7.  Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?

Authors:  Siran M Koroukian; Paul M Bakaki; Cynthia Owusu; Craig C Earle; Gregory S Cooper
Journal:  Medicare Medicaid Res Rev       Date:  2012-07-30

8.  Survival of women diagnosed with breast cancer and who have survived a previous cancer.

Authors:  Sandi L Pruitt; Hong Zhu; Daniel F Heitjan; Asal Rahimi; Bhumika Maddineni; Anna Tavakkoli; Ethan A Halm; David E Gerber; Danyi Xiong; Caitlin C Murphy
Journal:  Breast Cancer Res Treat       Date:  2021-02-23       Impact factor: 4.872

9.  Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries.

Authors:  Cathy J Bradley; Bassam Dahman; Paul M Bataki; Siran Koroukian
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

10.  Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert.

Authors:  Danya M Qato; Amal N Trivedi; Vincent Mor; David D Dore
Journal:  Med Care       Date:  2016-04       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.